Renal cell carcinoma: Evolving and emerging subtypes
|
摘要
Our knowledge of renal cell carcinoma(RCC) is rapidly expanding. For those who diagnose and treat RCC, it is important to understand the new developments. In recent years, many new renal tumors have been described and defined, and our understanding of the biology and clinical correlates of these tumors is changing. Evolving concepts in Xp11 translocation carcinoma, mucinous tubular and spindle cell carcinoma, multilocular cystic clear cell RCC, and carcinoma associated with neuroblastoma are addressed within this review. Tubulocystic carcinoma, thyroid-like follicular carcinoma of kidney, acquired cystic disease-associated RCC, and clear cell papillary RCC are also described. Finally, candidate entities, including RCC with t(6;11) translocation, hybrid oncocytoma/chromophobe RCC, hereditary leiomyomatosis and RCC syndrome, and renal angiomyoadenomatous tumor are reviewed. Knowledge of these new entities is important for diagnosis, treatment and subsequent prognosis. This review provides a targeted summary of new developments in RCC.
Our knowledge of renal cell carcinoma(RCC) is rapidly expanding. For those who diagnose and treat RCC, it is important to understand the new developments. In recent years, many new renal tumors have been described and defined, and our understanding of the biology and clinical correlates of these tumors is changing. Evolving concepts in Xp11 translocation carcinoma, mucinous tubular and spindle cell carcinoma, multilocular cystic clear cell RCC, and carcinoma associated with neuroblastoma are addressed within this review. Tubulocystic carcinoma, thyroid-like follicular carcinoma of kidney, acquired cystic disease-associated RCC, and clear cell papillary RCC are also described. Finally, candidate entities, including RCC with t(6;11) translocation, hybrid oncocytoma/chromophobe RCC, hereditary leiomyomatosis and RCC syndrome, and renal angiomyoadenomatous tumor are reviewed. Knowledge of these new entities is important for diagnosis, treatment and subsequent prognosis. This review provides a targeted summary of new developments in RCC.
Our knowledge of renal cell carcinoma(RCC) is rapidly expanding. For those who diagnose and treat RCC, it is important to understand the new developments. In recent years, many new renal tumors have been described and defined, and our understanding of the biology and clinical correlates of these tumors is changing. Evolving concepts in Xp11 translocation carcinoma, mucinous tubular and spindle cell carcinoma, multilocular cystic clear cell RCC, and carcinoma associated with neuroblastoma are addressed within this review. Tubulocystic carcinoma, thyroid-like follicular carcinoma of kidney, acquired cystic disease-associated RCC, and clear cell papillary RCC are also described. Finally, candidate entities, including RCC with t(6;11) translocation, hybrid oncocytoma/chromophobe RCC, hereditary leiomyomatosis and RCC syndrome, and renal angiomyoadenomatous tumor are reviewed. Knowledge of these new entities is important for diagnosis, treatment and subsequent prognosis. This review provides a targeted summary of new developments in RCC.
引文
1 Argani P,Ladanyi M.Renal carcinomas associated with Xp11.2 translocations/TFE3 gene fusions.In:Eble J,Sauter G,Epstein J,Sesterhenn I.World Health Organization Classification of Tumours:Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs.Lyon,France:IARC Press,2004:37
2 Argani P,Ladanyi M.Translocation carcinomas of the kidney.Clin Lab Med 2005;25:363-378[PMID:15848741 DOI:10 .1016/j.cll.2005.01.008]
3 Armah HB,Parwani AV.Xp11.2 translocation renal cell carcinoma.Arch Pathol Lab Med 2010;134:124-129[PMID:20073616 DOI:10.1043/2008-0391-RSR.1]
4 Shen SS,Truong LD,Ayala AG,Ro JY.Recently described and emphasized entities of renal neoplasms.Arch Pathol Lab Med 2007;131:1234-1243[PMID:17683186]
5 Argani P,Olgac S,Tickoo SK,Goldfischer M,Moch H,Chan DY,Eble JN,Bonsib SM,Jimeno M,Lloreta J,Billis A,Hicks J,De Marzo AM,Reuter VE,Ladanyi M.Xp11 translocation renal cell carcinoma in adults:expanded clinical,pathologic,and genetic spectrum.Am J Surg Pathol 2007;31:1149-1160[PMID:17667536 DOI:10.1097/PAS.0b013e318031ffff]
6 Suzigan S,Drut R,Faria P,Argani P,De Marzo AM,Barbosa RN,Mello Denadai ER,Martins-Filho J,Martucci RC,Bauab T.Xp11 translocation carcinoma of the kidney presenting with multilocular cystic renal cell carcinoma-like features.Int J Surg Pathol 2007;15:199-203[PMID:17478783DOI:10.1177/1066896906295891]
7 Argani P,LaéM,Ballard ET,Amin M,Manivel C,Hutchinson B,Reuter VE,Ladanyi M.Translocation carcinomas of the kidney after chemotherapy in childhood.J Clin Oncol 2006;24:1529-1534[PMID:16575003 DOI:10.1200/JCO.2005.04.4693]
8 Klatte T,Streubel B,Wrba F,Remzi M,Krammer B,de Martino M,Waldert M,Marberger M,Susani M,Haitel A.Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation:incidence,characteristics,and prognosis.Am J Clin Pathol 2012;137:761-768[PMID:22523215 DOI:10.1309/AJCPQ6LLFMC4OXGC]
9 Zhong M,De Angelo P,Osborne L,Paniz-Mondolfi AE,Geller M,Yang Y,Linehan WM,Merino MJ,Cordon-Cardo C,Cai D.Translocation renal cell carcinomas in adults:a singleinstitution experience.Am J Surg Pathol 2012;36:654-662[PMID:22446944 DOI:10.1097/PAS.0b013e31824f24a6]
10 Klaassen Z,Tatem A,Burnette JO,Donohoe JM,Terris MK.Adult Xp11 translocation associated renal cell carcinoma:time to recognize.Urology 2012;80:965-968[PMID:22999449DOI:10.1016/j.urology.2012.07.051]
11 Srigley J.Mucinous Tubular and Spindle Cell Carcinoma.In:Eble J,Sauter G,Epstein J,Sesterhenn I.Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs.Lyon:IARC Press,2004:40
12 Paner GP,Srigley JR,Radhakrishnan A,Cohen C,Skinnider BF,Tickoo SK,Young AN,Amin MB.Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney:significant immunophenotypic overlap warrants diagnostic caution.Am J Surg Pathol 2006;30:13-19[PMID:16330937]
13 Shen SS,Ro JY,Tamboli P,Truong LD,Zhai Q,Jung SJ,Tibbs RG,Ordonez NG,Ayala AG.Mucinous tubular and spindle cell carcinoma of kidney is probably a variant of papillary renal cell carcinoma with spindle cell features.Ann Diagn Pathol 2007;11:13-21[PMID:17240302 DOI:10.1016/j.anndiagpath.2006.09.005]
14 Cossu-Rocca P,Eble JN,Delahunt B,Zhang S,Martignoni G,Brunelli M,Cheng L.Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma.Mod Pathol 2006;19:488-493[PMID:16554730DOI:10.1038/modpathol.3800565]
15 Brandal P,Lie AK,Bassarova A,Svindland A,Risberg B,Danielsen H,Heim S.Genomic aberrations in mucinous tubular and spindle cell renal cell carcinomas.Mod Pathol2006;19:186-194[PMID:16258504 DOI:10.1038/modpathol.3800499]
16 Fine SW,Argani P,De Marzo AM,Delahunt B,Sebo TJ,Reuter VE,Epstein JI.Expanding the histologic spectrum of mucinous tubular and spindle cell carcinoma of the kidney.Am J Surg Pathol 2006;30:1554-1560[PMID:17122511 DOI:10 .1097/01.pas.0000213271.15221.e3]
17 Dhillon J,Amin MB,Selbs E,Turi GK,Paner GP,Reuter VE.Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid change.Am J Surg Pathol 2009;33:44-49[PMID:18941398 DOI:10.1097/PAS.0b013e3181829ed5]
18 Eble J.Multilocular cystic renal cell carcinoma.In:Eble J,Sauter G,Epstein J,Sesterhenn I.Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs.Lyon:IARC Press,2004:26
19 Williamson SR,Halat S,Eble JN,Grignon DJ,Lopez-Beltran A,Montironi R,Tan PH,Wang M,Zhang S,Maclennan GT,Baldridge LA,Cheng L.Multilocular cystic renal cell carcinoma:similarities and differences in immunoprofile compared with clear cell renal cell carcinoma.Am J Surg Pathol 2012;36:1425-1433[PMID:22982885 DOI:10.1097/PAS.0b013e31825b37f0]
20 Halat S,Eble JN,Grignon DJ,Lopez-Beltran A,Montironi R,Tan PH,Wang M,Zhang S,Mac Lennan GT,Cheng L.Multilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinoma.Mod Pathol 2010;23:931-936[PMID:20348877DOI:10.1038/modpathol.2010.78]
21 Suzigan S,López-Beltrán A,Montironi R,Drut R,Romero A,Hayashi T,Gentili AL,Fonseca PS,de Torres I,Billis A,Japp LC,Bollito E,Algaba F,Requena-Tapias MJ.Multilocular cystic renal cell carcinoma:a report of 45 cases of a kidney tumor of low malignant potential.Am J Clin Pathol 2006;125:217 -222[PMID:16393684 DOI:10.1309/AH6F-C77P-YR2V-6 YAY]
22 Medeiros L.Renal cell carcinoma associated with neuroblastoma.In:Eble J,Sauter G,Epstein J,Sesterhenn I.Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs.Lyon:IARC Press,2004:39
23 Medeiros LJ,Palmedo G,Krigman HR,Kovacs G,Beckwith JB.Oncocytoid renal cell carcinoma after neuroblastoma:a report of four cases of a distinct clinicopathologic entity.Am J Surg Pathol 1999;23:772-780[PMID:10403299]
24 Hedgepeth RC,Zhou M,Ross J.Rapid development of metastatic Xp11 translocation renal cell carcinoma in a girl treated for neuroblastoma.J Pediatr Hematol Oncol 2009;31:602-604[PMID:19636262 DOI:10.1097/MPH.0b013e3181acd981]
25 Altinok G,Kattar MM,Mohamed A,Poulik J,Grignon D,Rabah R.Pediatric renal carcinoma associated with Xp11.2translocations/TFE3 gene fusions and clinicopathologic associations.Pediatr Dev Pathol 2005;8:168-180[PMID:15747097 DOI:10.1007/s10024-004-9106-3]
26 Laverdière C,Liu Q,Yasui Y,Nathan PC,Gurney JG,Stovall M,Diller LR,Cheung NK,Wolden S,Robison LL,Sklar CA.Long-term outcomes in survivors of neuroblastoma:a report from the Childhood Cancer Survivor Study.J Natl Cancer Inst 2009;101:1131-1140[PMID:19648511 DOI:10.1093/jnci/djp230]
27 Bassal M,Mertens AC,Taylor L,Neglia JP,Greffe BS,Hammond S,Ronckers CM,Friedman DL,Stovall M,Yasui YY,Robison LL,Meadows AT,Kadan-Lottick NS.Risk of selected subsequent carcinomas in survivors of childhood cancer:a report from the Childhood Cancer Survivor Study.J Clin Oncol 2006;24:476-483[PMID:16421424 DOI:10.1200/JCO.2005.02.7235]
28 Amin MB,Mac Lennan GT,Gupta R,Grignon D,Paraf F,Vieillefond A,Paner GP,Stovsky M,Young AN,Srigley JR,Cheville JC.Tubulocystic carcinoma of the kidney:clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma.Am J Surg Pathol 2009;33:384-392[PMID:19011562 DOI:10.1097/PAS.0b013e3181872d3f]
29 Osunkoya AO,Young AN,Wang W,Netto GJ,Epstein JI.Comparison of gene expression profiles in tubulocystic carcinoma and collecting duct carcinoma of the kidney.Am J Surg Pathol 2009;33:1103-1106[PMID:19390420 DOI:10.1097/PAS.0b013e3181a13e7b]
30 Yang XJ,Zhou M,Hes O,Shen S,Li R,Lopez J,Shah RB,Yang Y,Chuang ST,Lin F,Tretiakova MM,Kort EJ,Teh BT.Tubulocystic carcinoma of the kidney:clinicopathologic and molecular characterization.Am J Surg Pathol 2008;32:177-187[PMID:18223319 DOI:10.1097/PAS.0b013e318150df1d]
31 Zhou M,Yang XJ,Lopez JI,Shah RB,Hes O,Shen SS,Li R,Yang Y,Lin F,Elson P,Sercia L,Magi-Galluzzi C,Tubbs R.Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma:implications for pathologic classification.Am J Surg Pathol 2009;33:1840-1849[PMID:19898225DOI:10.1097/PAS.0b013e3181be22d1]
32 Quiroga-Garza G,Pia-Oviedo S,Cuevas-Ocampo K,Goldfarb R,Schwartz MR,Ayala AG,Monzon FA.Synchronous clear cell renal cell carcinoma and tubulocystic carcinoma:genetic evidence of independent ontogenesis and implications of chromosomal imbalances in tumor progression.Diagn Pathol 2012;7:21[PMID:22369180 DOI:10 .1186/1746-1596-7-21]
33 Jung SJ,Chung JI,Park SH,Ayala AG,Ro JY.Thyroid follicular carcinoma-like tumor of kidney:a case report with morphologic,immunohistochemical,and genetic analysis.Am J Surg Pathol 2006;30:411-415[PMID:16538064 DOI:10 .1097/01.pas.0000194745.10670.dd]
34 Amin MB,Gupta R,Ondrej H,Mc Kenney JK,Michal M,Young AN,Paner GP,Junker K,Epstein JI.Primary thyroidlike follicular carcinoma of the kidney:report of 6 cases of a histologically distinctive adult renal epithelial neoplasm.Am J Surg Pathol 2009;33:393-400[PMID:19047894 DOI:10 .1097/PAS.0b013e31818cb8f5]
35 Dhillon J,Tannir NM,Matin SF,Tamboli P,Czerniak BA,Guo CC.Thyroid-like follicular carcinoma of the kidney with metastases to the lungs and retroperitoneal lymph nodes.Hum Pathol 2011;42:146-150[PMID:20971497 DOI:10 .1016/j.humpath.2010.01.026]
36 Khoja HA,Almutawa A,Binmahfooz A,Aslam M,Ghazi AA,Almaiman S.Papillary thyroid carcinoma-like tumor of the kidney:a case report.Int J Surg Pathol 2012;20:411-415[PMID:22158951 DOI:10.1177/1066896911429942]
37 Malde S,Sheikh I,Woodman I,Fish D,Bilagi P,Sheriff MK.Primary thyroid-like follicular renal cell carcinoma:an emerging entity.Case Rep Pathol 2013;2013:687427[PMID:23533895 DOI:10.1155/2013/687427]
38 Denton MD,Magee CC,Ovuworie C,Mauiyyedi S,Pascual M,Colvin RB,Cosimi AB,Tolkoff-Rubin N.Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation:a pathologic analysis.Kidney Int 2002;61:2201-2209[PMID:12028461 DOI:10.1046/j.1523-1755.2002.00374.x]
39 Choyke PL.Acquired cystic kidney disease.Eur Radiol 2000;10 :1716-1721[PMID:11097395]
40 Doublet JD,Peraldi MN,Gattegno B,Thibault P,Sraer JD.Renal cell carcinoma of native kidneys:prospective study of 129 renal transplant patients.J Urol 1997;158:42-44[PMID:9186319 DOI:10.1097/00005392-199707000-00012]
41 Hughson MD,Buchwald D,Fox M.Renal neoplasia and acquired cystic kidney disease in patients receiving longterm dialysis.Arch Pathol Lab Med 1986;110:592-601[PMID:3521533]
42 Tickoo SK,de Peralta-Venturina MN,Harik LR,Worcester HD,Salama ME,Young AN,Moch H,Amin MB.Spectrum of epithelial neoplasms in end-stage renal disease:an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.Am J Surg Pathol 2006;30:141-153[PMID:16434887]
43 Aydin H,Chen L,Cheng L,Vaziri S,He H,Ganapathi R,Delahunt B,Magi-Galluzzi C,Zhou M.Clear cell tubulopapillary renal cell carcinoma:a study of 36 distinctive low-grade epithelial tumors of the kidney.Am J Surg Pathol 2010;34:1608-1621[PMID:20924276 DOI:10.1097/PAS.0b013e3181f2ee0b]
44 Rohan SM,Xiao Y,Liang Y,Dudas ME,Al-Ahmadie HA,Fine SW,Gopalan A,Reuter VE,Rosenblum MK,Russo P,Tickoo SK.Clear-cell papillary renal cell carcinoma:molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins.Mod Pathol 2011;24:1207-1220[PMID:21602815DOI:10.1038/modpathol.2011.80]
45 Sule N,Yakupoglu U,Shen SS,Krishnan B,Yang G,Lerner S,Sheikh-Hamad D,Truong LD.Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease:a comprehensive study.Am J Surg Pathol 2005;29:443 -451[PMID:15767796]
46 Pan CC,Chen YJ,Chang LC,Chang YH,Ho DM.Immunohistochemical and molecular genetic profiling of acquired cystic disease-associated renal cell carcinoma.Histopathology 2009;55:145-153[PMID:19694821 DOI:10.1111/j.1365-2559.2009.03361.x]
47 Ishikawa I,Saito Y,Asaka M,Tomosugi N,Yuri T,Watanabe M,Honda R.Twenty-year follow-up of acquired renal cystic disease.Clin Nephrol 2003;59:153-159[PMID:12653256]
48 Kuroda N,Tamura M,Taguchi T,Tominaga A,Hes O,Michal M,Ohara M,Hirouchi T,Mizuno K,Hayashi Y,Shuin T,Lee GH.Sarcomatoid acquired cystic disease-associated renal cell carcinoma.Histol Histopathol 2008;23:1327-1331[PMID:18785115]
49 Chen YB,Tickoo SK.Spectrum of preneoplastic and neoplastic cystic lesions of the kidney.Arch Pathol Lab Med 2012;136 :400-409[PMID:22458902 DOI:10.5858/arpa.2011-0485-RA]
50 Gobbo S,Eble JN,Grignon DJ,Martignoni G,Mac Lennan GT,Shah RB,Zhang S,Brunelli M,Cheng L.Clear cell papillary renal cell carcinoma:a distinct histopathologic and molecular genetic entity.Am J Surg Pathol 2008;32:1239-1245[PMID:18594469DOI:10.1097/PAS.0b013e318164bcbb]
51 Adam J,Couturier J,MoliniéV,Vieillefond A,Sibony M.Clear-cell papillary renal cell carcinoma:24 cases of a distinct low-grade renal tumour and a comparative genomic hybridization array study of seven cases.Histopathology 2011;58:1064-1071[PMID:21707708 DOI:10.1111/j.1365-2559.2011.03857.x]
52 Bhatnagar R,Alexiev BA.Renal-cell carcinomas in endstage kidneys:a clinicopathological study with emphasis on clear-cell papillary renal-cell carcinoma and acquired cystic kidney disease-associated carcinoma.Int J Surg Pathol 2012;20 :19-28[PMID:21791489 DOI:10.1177/1066896911414273]
53 Williamson SR,Eble JN,Cheng L,Grignon DJ.Clear cell papillary renal cell carcinoma:differential diagnosis and extended immunohistochemical profile.Mod Pathol 2013;26:697 -708[PMID:23238627 DOI:10.1038/modpathol.2012.204]
54 Inoue T,Matsuura K,Yoshimoto T,Nguyen LT,Tsukamoto Y,Nakada C,Hijiya N,Narimatsu T,Nomura T,Sato F,Nagashima Y,Kashima K,Hatakeyama S,Ohyama C,Numakura K,Habuchi T,Nakagawa M,Seto M,Mimata H,Moriyama M.Genomic profiling of renal cell carcinoma in patients with end-stage renal disease.Cancer Sci 2012;103:569-576[PMID:22145865DOI:10.1111/j.1349-7006.2011.02176.x]
55 Wolfe A,Dobin SM,Grossmann P,Michal M,Donner LR.Clonal trisomies 7,10 and 12,normal 3p and absence of VHL gene mutation in a clear cell tubulopapillary carcinoma of the kidney.Virchows Arch 2011;459:457-463[PMID:21822960DOI:10.1007/s00428-011-1137-3]
56 Brannon AR,Haake SM,Hacker KE,Pruthi RS,Wallen EM,Nielsen ME,Rathmell WK.Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biology.Eur Urol 2012;61:258-268[PMID:22030119 DOI:10.1016/j.eururo.2011.10.007]
57 Argani P,Hawkins A,Griffin CA,Goldstein JD,Haas M,Beckwith JB,Mankinen CB,Perlman EJ.A distinctive pediatric renal neoplasm characterized by epithelioid morphology,basement membrane production,focal HMB45 immunoreactivity,and t(6;11)(p21.1;q12)chromosome translocation.Am J Pathol 2001;158:2089-2096[PMID:11395386 DOI:10.1016/S0002-9440(10)64680-9]
58 Argani P,LaéM,Hutchinson B,Reuter VE,Collins MH,Perentesis J,Tomaszewski JE,Brooks JS,Acs G,Bridge JA,Vargas SO,Davis IJ,Fisher DE,Ladanyi M.Renal carcinomas with the t(6;11)(p21;q12):clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry,RT-PCR,and DNA PCR.Am J Surg Pathol 2005;29:230-240[PMID:15644781]
59 Camparo P,Vasiliu V,Molinie V,Couturier J,Dykema KJ,Petillo D,Furge KA,Comperat EM,Lae M,Bouvier R,Boccon-Gibod L,Denoux Y,Ferlicot S,Forest E,Fromont G,Hintzy MC,Laghouati M,Sibony M,Tucker ML,Weber N,Teh BT,Vieillefond A.Renal translocation carcinomas:clinicopathologic,immunohistochemical,and gene expression profiling analysis of 31 cases with a review of the literature.Am J Surg Pathol 2008;32:656-670[PMID:18344867 DOI:10 .1097/PAS.0b013e3181609914]
60 Hora M,Hes O,Urge T,Eret V,Klecka J,Michal M.A distinctive translocation carcinoma of the kidney[“rosette-like forming,”t(6;11),HMB45-positive renal tumor].Int Urol Nephrol 2009;41:553-557[PMID:18998233 DOI:10.1007/s11255-008-9495-8]
61 Inamura K,Fujiwara M,Togashi Y,Nomura K,Mukai H,Fujii Y,Yamamoto S,Yonese J,Fukui I,Ishikawa Y.Diverse fusion patterns and heterogeneous clinicopathologic features of renal cell carcinoma with t(6;11)translocation.Am J Surg Pathol 2012;36:35-42[PMID:22173116 DOI:10.1097/PAS.0b013e3182293ec3]
62 Pecciarini L,Cangi MG,Lo Cunsolo C,Macri’E,Dal Cin E,Martignoni G,Doglioni C.Characterization of t(6;11)(p21;q12)in a renal-cell carcinoma of an adult patient.Genes Chromosomes Cancer 2007;46:419-426[PMID:17285572 DOI:10 .1002/gcc.20422]
63 Petersson F,Vaněek T,Michal M,Martignoni G,Brunelli M,Halbhuber Z,Spagnolo D,Kuroda N,Yang X,Cabrero IA,Hora M,Branovsky J,Trivunic S,KacerovskáD,Steiner P,Hes O.A distinctive translocation carcinoma of the kidney;“rosette forming,”t(6;11),HMB45-positive renal tumor:a histomorphologic,immunohistochemical,ultrastructural,and molecular genetic study of 4 cases.Hum Pathol 2012;43:726-736[PMID:22051379 DOI:10.1016/j.humpath.2011.07.001]
64 Suárez-Vilela D,Izquierdo-García F,Méndez-álvarez JR,Miguélez-García E,Domínguez-Iglesias F.Renal translocation carcinoma with expression of TFEB:presentation of a case with distinctive histological and immunohistochemical features.Int J Surg Pathol 2011;19:506-509[PMID:19687027DOI:10.1177/1066896909340531]
65 Zhan HQ,Wang CF,Zhu XZ,Xu XL.Renal cell carcinoma with t(6;11)translocation:a patient case with a novel AlphaTFEB fusion point.J Clin Oncol 2010;28:e709-e713[PMID:20823414 DOI:10.1200/JCO.2010.30.3172]
66 Rao Q,Liu B,Cheng L,Zhu Y,Shi QL,Wu B,Jiang SJ,Wang Y,Wang X,Yu B,Zhang RS,Ma HH,Lu ZF,Tu P,Wang JD,Zhou XJ.Renal cell carcinomas with t(6;11)(p21;q12):A clinicopathologic study emphasizing unusual morphology,novel alpha-TFEB gene fusion point,immunobiomarkers,and ultrastructural features,as well as detection of the gene fusion by fluorescence in situ hybridization.Am J Surg Pathol 2012;36:1327-1338[PMID:22895266 DOI:10.1097/PAS.0b013e31825aafb5]
67 Martignoni G,Pea M,Gobbo S,Brunelli M,Bonetti F,Segala D,Pan CC,Netto G,Doglioni C,Hes O,Argani P,Chilosi M.Cathepsin-K immunoreactivity distinguishes Mi TF/TFE family renal translocation carcinomas from other renal carcinomas.Mod Pathol 2009;22:1016-1022[PMID:19396149 DOI:10 .1038/modpathol.2009.58]
68 Argani P,Yonescu R,Morsberger L,Morris K,Netto GJ,Smith N,Gonzalez N,Illei PB,Ladanyi M,Griffin CA.Molecular confirmation of t(6;11)(p21;q12)renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum.Am J Surg Pathol 2012;36:1516-1526[PMID:22892601 DOI:10 .1097/PAS.0b013e3182613d8f]
69 Pavlovich CP,Walther MM,Eyler RA,Hewitt SM,Zbar B,Linehan WM,Merino MJ.Renal tumors in the Birt-HoggDubésyndrome.Am J Surg Pathol 2002;26:1542-1552[PMID:12459621]
70 Linehan WM,Pinto PA,Bratslavsky G,Pfaffenroth E,Merino M,Vocke CD,Toro JR,Bottaro D,Neckers L,Schmidt LS,Srinivasan R.Hereditary kidney cancer:unique opportunity for disease-based therapy.Cancer 2009;115:2252-2261[PMID:19402075 DOI:10.1002/cncr.24230]
71 Petersson F,Gatalica Z,Grossmann P,Perez Montiel MD,Alvarado Cabrero I,Bulimbasic S,Swatek A,Straka L,Tichy T,Hora M,Kuroda N,Legendre B,Michal M,Hes O.Sporadic hybrid oncocytic/chromophobe tumor of the kidney:a clinicopathologic,histomorphologic,immunohistochemical,ultrastructural,and molecular cytogenetic study of 14 cases.Virchows Arch 2010;456:355-365[PMID:20300772 DOI:10 .1007/s00428-010-0898-4]
72 Delongchamps NB,Galmiche L,Eiss D,Rouach Y,Vogt B,Timsit MO,Vieillefond A,Méjean A.Hybrid tumour‘oncocytoma-chromophobe renal cell carcinoma’of the kidney:a report of seven sporadic cases.BJU Int 2009;103:1381-1384[PMID:19154497 DOI:10.1111/j.1464-410X.2008.08263.x]
73 Waldert M,Klatte T,Haitel A,Ozsoy M,Schmidbauer J,Marberger M,Remzi M.Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes.Eur Urol 2010;57:661-665[PMID:19477583 DOI:10 .1016/j.eururo.2009.05.009]
74 Launonen V,Vierimaa O,Kiuru M,Isola J,Roth S,Pukkala E,Sistonen P,Herva R,Aaltonen LA.Inherited susceptibility to uterine leiomyomas and renal cell cancer.Proc Natl Acad Sci U S A 2001;98:3387-3392[PMID:11248088 DOI:10.1073/pnas.051633798]
75 Toro JR,Nickerson ML,Wei MH,Warren MB,Glenn GM,Turner ML,Stewart L,Duray P,Tourre O,Sharma N,Choyke P,Stratton P,Merino M,Walther MM,Linehan WM,Schmidt LS,Zbar B.Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell can-cer in families in North America.Am J Hum Genet 2003;73:95 -106[PMID:12772087 DOI:10.1086/376435]
76 Tomlinson IP,Alam NA,Rowan AJ,Barclay E,Jaeger EE,Kelsell D,Leigh I,Gorman P,Lamlum H,Rahman S,Roylance RR,Olpin S,Bevan S,Barker K,Hearle N,Houlston RS,Kiuru M,Lehtonen R,Karhu A,Vilkki S,Laiho P,Eklund C,Vierimaa O,Aittomki K,Hietala M,Sistonen P,Paetau A,Salovaara R,Herva R,Launonen V,Aaltonen LA.Germline mutations in FH predispose to dominantly inherited uterine fibroids,skin leiomyomata and papillary renal cell cancer.Nat Genet 2002;30:406-410[PMID:11865300 DOI:10.1038/ng849]
77 Wei MH,Toure O,Glenn GM,Pithukpakorn M,Neckers L,Stolle C,Choyke P,Grubb R,Middelton L,Turner ML,Walther MM,Merino MJ,Zbar B,Linehan WM,Toro JR.Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer.J Med Genet 2006;43:18-27[PMID:15937070 DOI:10.1136/jmg.2005.033506]
78 Reed WB,Walker R,Horowitz R.Cutaneous leiomyomata with uterine leiomyomata.Acta Derm Venereol 1973;53:409 -416[PMID:4127477]
79 Merino MJ,Torres-Cabala C,Pinto P,Linehan WM.The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma(HLRCC)syndrome.Am J Surg Pathol 2007;31:1578-1585[PMID:17895761 DOI:10 .1097/PAS.0b013e31804375b8]
80 Sanz-Ortega J,Vocke C,Stratton P,Linehan WM,Merino MJ.Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer(HLRCC)syndrome.Am J Surg Pathol 2013;37:74-80[PMID:23211287 DOI:10.1097/PAS.0b013e31825ec16f]
81 Michal M,Hes O,Nemcova J,Sima R,Kuroda N,Bulimbasic S,Franco M,Sakaida N,Danis D,Kazakov DV,Ohe C,Hora M.Renal angiomyoadenomatous tumor:morphologic,immunohistochemical,and molecular genetic study of a distinct entity.Virchows Arch 2009;454:89-99[PMID:19020896DOI:10.1007/s00428-008-0697-3]
82 Kuhn E,De Anda J,Manoni S,Netto G,Rosai J.Renal cell carcinoma associated with prominent angioleiomyoma-like proliferation:Report of 5 cases and review of the literature.Am J Surg Pathol 2006;30:1372-1381[PMID:17063076 DOI:10 .1097/01.pas.0000213277.45715.82]
83 Shannon BA,Cohen RJ,Segal A,Baker EG,Murch AR.Clear cell renal cell carcinoma with smooth muscle stroma.Hum Pathol 2009;40:425-429[PMID:18789480 DOI:10.1016/j.humpath.2008.05.021]
84 Michal M,Hes O,Kuroda N,Kazakov DV,Hora M.Difference between RAT and clear cell papillary renal cell carcinoma/clear renal cell carcinoma.Virchows Arch 2009;454:719 [PMID:19471960 DOI:10.1007/s00428-009-0788-9]
85 Kuroda N,Hosokawa T,Michal M,Hes O,Sima R,Ohe C,Lee GH.Clear cell renal cell carcinoma with focal renal angiomyoadenomatous tumor-like area.Ann Diagn Pathol 2011;15 :202-206[PMID:20952290 DOI:10.1016/j.anndiagpath.2010.03.003]
86 Kuroda N,Michal M,Hes O,Taguchi T,Tominaga A,Mizobuchi K,Ohe C,Sakaida N,Uemura Y,Shuin T,Lee GH.Renal angiomyoadenomatous tumor:fluorescence in situ hybridization.Pathol Int 2009;59:689-691[PMID:19712141DOI:10.1111/j.1440-1827.2009.02429.x]
87 Petersson F,Yan B,Huang J,Thamboo TP,Bing TK,Consigliere DT.Low-grade renal carcinoma with histologic features overlapping with renal angiomyoadenomatous tumor and featuring polysomy 7 and 17 and a mutation in the von Hippel-Lindau gene:report of a hybrid tumor and a few comments on renal angiomyoadenomatous tumor and papillary renal tumors with clear cells.Ann Diagn Pathol 2011;15:213 -216[PMID:21396864 DOI:10.1016/j.anndiagpath.2010.10.005]
88 Verine J.Renal angiomyoadenomatous tumor:morphologic,immunohistochemical,and molecular genetic study of a distinct entity.Virchows Arch 2009;454:479-480[PMID:19205727 DOI:10.1007/s00428-009-0741-y]
2 Argani P,Ladanyi M.Translocation carcinomas of the kidney.Clin Lab Med 2005;25:363-378[PMID:15848741 DOI:10 .1016/j.cll.2005.01.008]
3 Armah HB,Parwani AV.Xp11.2 translocation renal cell carcinoma.Arch Pathol Lab Med 2010;134:124-129[PMID:20073616 DOI:10.1043/2008-0391-RSR.1]
4 Shen SS,Truong LD,Ayala AG,Ro JY.Recently described and emphasized entities of renal neoplasms.Arch Pathol Lab Med 2007;131:1234-1243[PMID:17683186]
5 Argani P,Olgac S,Tickoo SK,Goldfischer M,Moch H,Chan DY,Eble JN,Bonsib SM,Jimeno M,Lloreta J,Billis A,Hicks J,De Marzo AM,Reuter VE,Ladanyi M.Xp11 translocation renal cell carcinoma in adults:expanded clinical,pathologic,and genetic spectrum.Am J Surg Pathol 2007;31:1149-1160[PMID:17667536 DOI:10.1097/PAS.0b013e318031ffff]
6 Suzigan S,Drut R,Faria P,Argani P,De Marzo AM,Barbosa RN,Mello Denadai ER,Martins-Filho J,Martucci RC,Bauab T.Xp11 translocation carcinoma of the kidney presenting with multilocular cystic renal cell carcinoma-like features.Int J Surg Pathol 2007;15:199-203[PMID:17478783DOI:10.1177/1066896906295891]
7 Argani P,LaéM,Ballard ET,Amin M,Manivel C,Hutchinson B,Reuter VE,Ladanyi M.Translocation carcinomas of the kidney after chemotherapy in childhood.J Clin Oncol 2006;24:1529-1534[PMID:16575003 DOI:10.1200/JCO.2005.04.4693]
8 Klatte T,Streubel B,Wrba F,Remzi M,Krammer B,de Martino M,Waldert M,Marberger M,Susani M,Haitel A.Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation:incidence,characteristics,and prognosis.Am J Clin Pathol 2012;137:761-768[PMID:22523215 DOI:10.1309/AJCPQ6LLFMC4OXGC]
9 Zhong M,De Angelo P,Osborne L,Paniz-Mondolfi AE,Geller M,Yang Y,Linehan WM,Merino MJ,Cordon-Cardo C,Cai D.Translocation renal cell carcinomas in adults:a singleinstitution experience.Am J Surg Pathol 2012;36:654-662[PMID:22446944 DOI:10.1097/PAS.0b013e31824f24a6]
10 Klaassen Z,Tatem A,Burnette JO,Donohoe JM,Terris MK.Adult Xp11 translocation associated renal cell carcinoma:time to recognize.Urology 2012;80:965-968[PMID:22999449DOI:10.1016/j.urology.2012.07.051]
11 Srigley J.Mucinous Tubular and Spindle Cell Carcinoma.In:Eble J,Sauter G,Epstein J,Sesterhenn I.Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs.Lyon:IARC Press,2004:40
12 Paner GP,Srigley JR,Radhakrishnan A,Cohen C,Skinnider BF,Tickoo SK,Young AN,Amin MB.Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney:significant immunophenotypic overlap warrants diagnostic caution.Am J Surg Pathol 2006;30:13-19[PMID:16330937]
13 Shen SS,Ro JY,Tamboli P,Truong LD,Zhai Q,Jung SJ,Tibbs RG,Ordonez NG,Ayala AG.Mucinous tubular and spindle cell carcinoma of kidney is probably a variant of papillary renal cell carcinoma with spindle cell features.Ann Diagn Pathol 2007;11:13-21[PMID:17240302 DOI:10.1016/j.anndiagpath.2006.09.005]
14 Cossu-Rocca P,Eble JN,Delahunt B,Zhang S,Martignoni G,Brunelli M,Cheng L.Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma.Mod Pathol 2006;19:488-493[PMID:16554730DOI:10.1038/modpathol.3800565]
15 Brandal P,Lie AK,Bassarova A,Svindland A,Risberg B,Danielsen H,Heim S.Genomic aberrations in mucinous tubular and spindle cell renal cell carcinomas.Mod Pathol2006;19:186-194[PMID:16258504 DOI:10.1038/modpathol.3800499]
16 Fine SW,Argani P,De Marzo AM,Delahunt B,Sebo TJ,Reuter VE,Epstein JI.Expanding the histologic spectrum of mucinous tubular and spindle cell carcinoma of the kidney.Am J Surg Pathol 2006;30:1554-1560[PMID:17122511 DOI:10 .1097/01.pas.0000213271.15221.e3]
17 Dhillon J,Amin MB,Selbs E,Turi GK,Paner GP,Reuter VE.Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid change.Am J Surg Pathol 2009;33:44-49[PMID:18941398 DOI:10.1097/PAS.0b013e3181829ed5]
18 Eble J.Multilocular cystic renal cell carcinoma.In:Eble J,Sauter G,Epstein J,Sesterhenn I.Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs.Lyon:IARC Press,2004:26
19 Williamson SR,Halat S,Eble JN,Grignon DJ,Lopez-Beltran A,Montironi R,Tan PH,Wang M,Zhang S,Maclennan GT,Baldridge LA,Cheng L.Multilocular cystic renal cell carcinoma:similarities and differences in immunoprofile compared with clear cell renal cell carcinoma.Am J Surg Pathol 2012;36:1425-1433[PMID:22982885 DOI:10.1097/PAS.0b013e31825b37f0]
20 Halat S,Eble JN,Grignon DJ,Lopez-Beltran A,Montironi R,Tan PH,Wang M,Zhang S,Mac Lennan GT,Cheng L.Multilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinoma.Mod Pathol 2010;23:931-936[PMID:20348877DOI:10.1038/modpathol.2010.78]
21 Suzigan S,López-Beltrán A,Montironi R,Drut R,Romero A,Hayashi T,Gentili AL,Fonseca PS,de Torres I,Billis A,Japp LC,Bollito E,Algaba F,Requena-Tapias MJ.Multilocular cystic renal cell carcinoma:a report of 45 cases of a kidney tumor of low malignant potential.Am J Clin Pathol 2006;125:217 -222[PMID:16393684 DOI:10.1309/AH6F-C77P-YR2V-6 YAY]
22 Medeiros L.Renal cell carcinoma associated with neuroblastoma.In:Eble J,Sauter G,Epstein J,Sesterhenn I.Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs.Lyon:IARC Press,2004:39
23 Medeiros LJ,Palmedo G,Krigman HR,Kovacs G,Beckwith JB.Oncocytoid renal cell carcinoma after neuroblastoma:a report of four cases of a distinct clinicopathologic entity.Am J Surg Pathol 1999;23:772-780[PMID:10403299]
24 Hedgepeth RC,Zhou M,Ross J.Rapid development of metastatic Xp11 translocation renal cell carcinoma in a girl treated for neuroblastoma.J Pediatr Hematol Oncol 2009;31:602-604[PMID:19636262 DOI:10.1097/MPH.0b013e3181acd981]
25 Altinok G,Kattar MM,Mohamed A,Poulik J,Grignon D,Rabah R.Pediatric renal carcinoma associated with Xp11.2translocations/TFE3 gene fusions and clinicopathologic associations.Pediatr Dev Pathol 2005;8:168-180[PMID:15747097 DOI:10.1007/s10024-004-9106-3]
26 Laverdière C,Liu Q,Yasui Y,Nathan PC,Gurney JG,Stovall M,Diller LR,Cheung NK,Wolden S,Robison LL,Sklar CA.Long-term outcomes in survivors of neuroblastoma:a report from the Childhood Cancer Survivor Study.J Natl Cancer Inst 2009;101:1131-1140[PMID:19648511 DOI:10.1093/jnci/djp230]
27 Bassal M,Mertens AC,Taylor L,Neglia JP,Greffe BS,Hammond S,Ronckers CM,Friedman DL,Stovall M,Yasui YY,Robison LL,Meadows AT,Kadan-Lottick NS.Risk of selected subsequent carcinomas in survivors of childhood cancer:a report from the Childhood Cancer Survivor Study.J Clin Oncol 2006;24:476-483[PMID:16421424 DOI:10.1200/JCO.2005.02.7235]
28 Amin MB,Mac Lennan GT,Gupta R,Grignon D,Paraf F,Vieillefond A,Paner GP,Stovsky M,Young AN,Srigley JR,Cheville JC.Tubulocystic carcinoma of the kidney:clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma.Am J Surg Pathol 2009;33:384-392[PMID:19011562 DOI:10.1097/PAS.0b013e3181872d3f]
29 Osunkoya AO,Young AN,Wang W,Netto GJ,Epstein JI.Comparison of gene expression profiles in tubulocystic carcinoma and collecting duct carcinoma of the kidney.Am J Surg Pathol 2009;33:1103-1106[PMID:19390420 DOI:10.1097/PAS.0b013e3181a13e7b]
30 Yang XJ,Zhou M,Hes O,Shen S,Li R,Lopez J,Shah RB,Yang Y,Chuang ST,Lin F,Tretiakova MM,Kort EJ,Teh BT.Tubulocystic carcinoma of the kidney:clinicopathologic and molecular characterization.Am J Surg Pathol 2008;32:177-187[PMID:18223319 DOI:10.1097/PAS.0b013e318150df1d]
31 Zhou M,Yang XJ,Lopez JI,Shah RB,Hes O,Shen SS,Li R,Yang Y,Lin F,Elson P,Sercia L,Magi-Galluzzi C,Tubbs R.Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma:implications for pathologic classification.Am J Surg Pathol 2009;33:1840-1849[PMID:19898225DOI:10.1097/PAS.0b013e3181be22d1]
32 Quiroga-Garza G,Pia-Oviedo S,Cuevas-Ocampo K,Goldfarb R,Schwartz MR,Ayala AG,Monzon FA.Synchronous clear cell renal cell carcinoma and tubulocystic carcinoma:genetic evidence of independent ontogenesis and implications of chromosomal imbalances in tumor progression.Diagn Pathol 2012;7:21[PMID:22369180 DOI:10 .1186/1746-1596-7-21]
33 Jung SJ,Chung JI,Park SH,Ayala AG,Ro JY.Thyroid follicular carcinoma-like tumor of kidney:a case report with morphologic,immunohistochemical,and genetic analysis.Am J Surg Pathol 2006;30:411-415[PMID:16538064 DOI:10 .1097/01.pas.0000194745.10670.dd]
34 Amin MB,Gupta R,Ondrej H,Mc Kenney JK,Michal M,Young AN,Paner GP,Junker K,Epstein JI.Primary thyroidlike follicular carcinoma of the kidney:report of 6 cases of a histologically distinctive adult renal epithelial neoplasm.Am J Surg Pathol 2009;33:393-400[PMID:19047894 DOI:10 .1097/PAS.0b013e31818cb8f5]
35 Dhillon J,Tannir NM,Matin SF,Tamboli P,Czerniak BA,Guo CC.Thyroid-like follicular carcinoma of the kidney with metastases to the lungs and retroperitoneal lymph nodes.Hum Pathol 2011;42:146-150[PMID:20971497 DOI:10 .1016/j.humpath.2010.01.026]
36 Khoja HA,Almutawa A,Binmahfooz A,Aslam M,Ghazi AA,Almaiman S.Papillary thyroid carcinoma-like tumor of the kidney:a case report.Int J Surg Pathol 2012;20:411-415[PMID:22158951 DOI:10.1177/1066896911429942]
37 Malde S,Sheikh I,Woodman I,Fish D,Bilagi P,Sheriff MK.Primary thyroid-like follicular renal cell carcinoma:an emerging entity.Case Rep Pathol 2013;2013:687427[PMID:23533895 DOI:10.1155/2013/687427]
38 Denton MD,Magee CC,Ovuworie C,Mauiyyedi S,Pascual M,Colvin RB,Cosimi AB,Tolkoff-Rubin N.Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation:a pathologic analysis.Kidney Int 2002;61:2201-2209[PMID:12028461 DOI:10.1046/j.1523-1755.2002.00374.x]
39 Choyke PL.Acquired cystic kidney disease.Eur Radiol 2000;10 :1716-1721[PMID:11097395]
40 Doublet JD,Peraldi MN,Gattegno B,Thibault P,Sraer JD.Renal cell carcinoma of native kidneys:prospective study of 129 renal transplant patients.J Urol 1997;158:42-44[PMID:9186319 DOI:10.1097/00005392-199707000-00012]
41 Hughson MD,Buchwald D,Fox M.Renal neoplasia and acquired cystic kidney disease in patients receiving longterm dialysis.Arch Pathol Lab Med 1986;110:592-601[PMID:3521533]
42 Tickoo SK,de Peralta-Venturina MN,Harik LR,Worcester HD,Salama ME,Young AN,Moch H,Amin MB.Spectrum of epithelial neoplasms in end-stage renal disease:an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.Am J Surg Pathol 2006;30:141-153[PMID:16434887]
43 Aydin H,Chen L,Cheng L,Vaziri S,He H,Ganapathi R,Delahunt B,Magi-Galluzzi C,Zhou M.Clear cell tubulopapillary renal cell carcinoma:a study of 36 distinctive low-grade epithelial tumors of the kidney.Am J Surg Pathol 2010;34:1608-1621[PMID:20924276 DOI:10.1097/PAS.0b013e3181f2ee0b]
44 Rohan SM,Xiao Y,Liang Y,Dudas ME,Al-Ahmadie HA,Fine SW,Gopalan A,Reuter VE,Rosenblum MK,Russo P,Tickoo SK.Clear-cell papillary renal cell carcinoma:molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins.Mod Pathol 2011;24:1207-1220[PMID:21602815DOI:10.1038/modpathol.2011.80]
45 Sule N,Yakupoglu U,Shen SS,Krishnan B,Yang G,Lerner S,Sheikh-Hamad D,Truong LD.Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease:a comprehensive study.Am J Surg Pathol 2005;29:443 -451[PMID:15767796]
46 Pan CC,Chen YJ,Chang LC,Chang YH,Ho DM.Immunohistochemical and molecular genetic profiling of acquired cystic disease-associated renal cell carcinoma.Histopathology 2009;55:145-153[PMID:19694821 DOI:10.1111/j.1365-2559.2009.03361.x]
47 Ishikawa I,Saito Y,Asaka M,Tomosugi N,Yuri T,Watanabe M,Honda R.Twenty-year follow-up of acquired renal cystic disease.Clin Nephrol 2003;59:153-159[PMID:12653256]
48 Kuroda N,Tamura M,Taguchi T,Tominaga A,Hes O,Michal M,Ohara M,Hirouchi T,Mizuno K,Hayashi Y,Shuin T,Lee GH.Sarcomatoid acquired cystic disease-associated renal cell carcinoma.Histol Histopathol 2008;23:1327-1331[PMID:18785115]
49 Chen YB,Tickoo SK.Spectrum of preneoplastic and neoplastic cystic lesions of the kidney.Arch Pathol Lab Med 2012;136 :400-409[PMID:22458902 DOI:10.5858/arpa.2011-0485-RA]
50 Gobbo S,Eble JN,Grignon DJ,Martignoni G,Mac Lennan GT,Shah RB,Zhang S,Brunelli M,Cheng L.Clear cell papillary renal cell carcinoma:a distinct histopathologic and molecular genetic entity.Am J Surg Pathol 2008;32:1239-1245[PMID:18594469DOI:10.1097/PAS.0b013e318164bcbb]
51 Adam J,Couturier J,MoliniéV,Vieillefond A,Sibony M.Clear-cell papillary renal cell carcinoma:24 cases of a distinct low-grade renal tumour and a comparative genomic hybridization array study of seven cases.Histopathology 2011;58:1064-1071[PMID:21707708 DOI:10.1111/j.1365-2559.2011.03857.x]
52 Bhatnagar R,Alexiev BA.Renal-cell carcinomas in endstage kidneys:a clinicopathological study with emphasis on clear-cell papillary renal-cell carcinoma and acquired cystic kidney disease-associated carcinoma.Int J Surg Pathol 2012;20 :19-28[PMID:21791489 DOI:10.1177/1066896911414273]
53 Williamson SR,Eble JN,Cheng L,Grignon DJ.Clear cell papillary renal cell carcinoma:differential diagnosis and extended immunohistochemical profile.Mod Pathol 2013;26:697 -708[PMID:23238627 DOI:10.1038/modpathol.2012.204]
54 Inoue T,Matsuura K,Yoshimoto T,Nguyen LT,Tsukamoto Y,Nakada C,Hijiya N,Narimatsu T,Nomura T,Sato F,Nagashima Y,Kashima K,Hatakeyama S,Ohyama C,Numakura K,Habuchi T,Nakagawa M,Seto M,Mimata H,Moriyama M.Genomic profiling of renal cell carcinoma in patients with end-stage renal disease.Cancer Sci 2012;103:569-576[PMID:22145865DOI:10.1111/j.1349-7006.2011.02176.x]
55 Wolfe A,Dobin SM,Grossmann P,Michal M,Donner LR.Clonal trisomies 7,10 and 12,normal 3p and absence of VHL gene mutation in a clear cell tubulopapillary carcinoma of the kidney.Virchows Arch 2011;459:457-463[PMID:21822960DOI:10.1007/s00428-011-1137-3]
56 Brannon AR,Haake SM,Hacker KE,Pruthi RS,Wallen EM,Nielsen ME,Rathmell WK.Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biology.Eur Urol 2012;61:258-268[PMID:22030119 DOI:10.1016/j.eururo.2011.10.007]
57 Argani P,Hawkins A,Griffin CA,Goldstein JD,Haas M,Beckwith JB,Mankinen CB,Perlman EJ.A distinctive pediatric renal neoplasm characterized by epithelioid morphology,basement membrane production,focal HMB45 immunoreactivity,and t(6;11)(p21.1;q12)chromosome translocation.Am J Pathol 2001;158:2089-2096[PMID:11395386 DOI:10.1016/S0002-9440(10)64680-9]
58 Argani P,LaéM,Hutchinson B,Reuter VE,Collins MH,Perentesis J,Tomaszewski JE,Brooks JS,Acs G,Bridge JA,Vargas SO,Davis IJ,Fisher DE,Ladanyi M.Renal carcinomas with the t(6;11)(p21;q12):clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry,RT-PCR,and DNA PCR.Am J Surg Pathol 2005;29:230-240[PMID:15644781]
59 Camparo P,Vasiliu V,Molinie V,Couturier J,Dykema KJ,Petillo D,Furge KA,Comperat EM,Lae M,Bouvier R,Boccon-Gibod L,Denoux Y,Ferlicot S,Forest E,Fromont G,Hintzy MC,Laghouati M,Sibony M,Tucker ML,Weber N,Teh BT,Vieillefond A.Renal translocation carcinomas:clinicopathologic,immunohistochemical,and gene expression profiling analysis of 31 cases with a review of the literature.Am J Surg Pathol 2008;32:656-670[PMID:18344867 DOI:10 .1097/PAS.0b013e3181609914]
60 Hora M,Hes O,Urge T,Eret V,Klecka J,Michal M.A distinctive translocation carcinoma of the kidney[“rosette-like forming,”t(6;11),HMB45-positive renal tumor].Int Urol Nephrol 2009;41:553-557[PMID:18998233 DOI:10.1007/s11255-008-9495-8]
61 Inamura K,Fujiwara M,Togashi Y,Nomura K,Mukai H,Fujii Y,Yamamoto S,Yonese J,Fukui I,Ishikawa Y.Diverse fusion patterns and heterogeneous clinicopathologic features of renal cell carcinoma with t(6;11)translocation.Am J Surg Pathol 2012;36:35-42[PMID:22173116 DOI:10.1097/PAS.0b013e3182293ec3]
62 Pecciarini L,Cangi MG,Lo Cunsolo C,Macri’E,Dal Cin E,Martignoni G,Doglioni C.Characterization of t(6;11)(p21;q12)in a renal-cell carcinoma of an adult patient.Genes Chromosomes Cancer 2007;46:419-426[PMID:17285572 DOI:10 .1002/gcc.20422]
63 Petersson F,Vaněek T,Michal M,Martignoni G,Brunelli M,Halbhuber Z,Spagnolo D,Kuroda N,Yang X,Cabrero IA,Hora M,Branovsky J,Trivunic S,KacerovskáD,Steiner P,Hes O.A distinctive translocation carcinoma of the kidney;“rosette forming,”t(6;11),HMB45-positive renal tumor:a histomorphologic,immunohistochemical,ultrastructural,and molecular genetic study of 4 cases.Hum Pathol 2012;43:726-736[PMID:22051379 DOI:10.1016/j.humpath.2011.07.001]
64 Suárez-Vilela D,Izquierdo-García F,Méndez-álvarez JR,Miguélez-García E,Domínguez-Iglesias F.Renal translocation carcinoma with expression of TFEB:presentation of a case with distinctive histological and immunohistochemical features.Int J Surg Pathol 2011;19:506-509[PMID:19687027DOI:10.1177/1066896909340531]
65 Zhan HQ,Wang CF,Zhu XZ,Xu XL.Renal cell carcinoma with t(6;11)translocation:a patient case with a novel AlphaTFEB fusion point.J Clin Oncol 2010;28:e709-e713[PMID:20823414 DOI:10.1200/JCO.2010.30.3172]
66 Rao Q,Liu B,Cheng L,Zhu Y,Shi QL,Wu B,Jiang SJ,Wang Y,Wang X,Yu B,Zhang RS,Ma HH,Lu ZF,Tu P,Wang JD,Zhou XJ.Renal cell carcinomas with t(6;11)(p21;q12):A clinicopathologic study emphasizing unusual morphology,novel alpha-TFEB gene fusion point,immunobiomarkers,and ultrastructural features,as well as detection of the gene fusion by fluorescence in situ hybridization.Am J Surg Pathol 2012;36:1327-1338[PMID:22895266 DOI:10.1097/PAS.0b013e31825aafb5]
67 Martignoni G,Pea M,Gobbo S,Brunelli M,Bonetti F,Segala D,Pan CC,Netto G,Doglioni C,Hes O,Argani P,Chilosi M.Cathepsin-K immunoreactivity distinguishes Mi TF/TFE family renal translocation carcinomas from other renal carcinomas.Mod Pathol 2009;22:1016-1022[PMID:19396149 DOI:10 .1038/modpathol.2009.58]
68 Argani P,Yonescu R,Morsberger L,Morris K,Netto GJ,Smith N,Gonzalez N,Illei PB,Ladanyi M,Griffin CA.Molecular confirmation of t(6;11)(p21;q12)renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum.Am J Surg Pathol 2012;36:1516-1526[PMID:22892601 DOI:10 .1097/PAS.0b013e3182613d8f]
69 Pavlovich CP,Walther MM,Eyler RA,Hewitt SM,Zbar B,Linehan WM,Merino MJ.Renal tumors in the Birt-HoggDubésyndrome.Am J Surg Pathol 2002;26:1542-1552[PMID:12459621]
70 Linehan WM,Pinto PA,Bratslavsky G,Pfaffenroth E,Merino M,Vocke CD,Toro JR,Bottaro D,Neckers L,Schmidt LS,Srinivasan R.Hereditary kidney cancer:unique opportunity for disease-based therapy.Cancer 2009;115:2252-2261[PMID:19402075 DOI:10.1002/cncr.24230]
71 Petersson F,Gatalica Z,Grossmann P,Perez Montiel MD,Alvarado Cabrero I,Bulimbasic S,Swatek A,Straka L,Tichy T,Hora M,Kuroda N,Legendre B,Michal M,Hes O.Sporadic hybrid oncocytic/chromophobe tumor of the kidney:a clinicopathologic,histomorphologic,immunohistochemical,ultrastructural,and molecular cytogenetic study of 14 cases.Virchows Arch 2010;456:355-365[PMID:20300772 DOI:10 .1007/s00428-010-0898-4]
72 Delongchamps NB,Galmiche L,Eiss D,Rouach Y,Vogt B,Timsit MO,Vieillefond A,Méjean A.Hybrid tumour‘oncocytoma-chromophobe renal cell carcinoma’of the kidney:a report of seven sporadic cases.BJU Int 2009;103:1381-1384[PMID:19154497 DOI:10.1111/j.1464-410X.2008.08263.x]
73 Waldert M,Klatte T,Haitel A,Ozsoy M,Schmidbauer J,Marberger M,Remzi M.Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes.Eur Urol 2010;57:661-665[PMID:19477583 DOI:10 .1016/j.eururo.2009.05.009]
74 Launonen V,Vierimaa O,Kiuru M,Isola J,Roth S,Pukkala E,Sistonen P,Herva R,Aaltonen LA.Inherited susceptibility to uterine leiomyomas and renal cell cancer.Proc Natl Acad Sci U S A 2001;98:3387-3392[PMID:11248088 DOI:10.1073/pnas.051633798]
75 Toro JR,Nickerson ML,Wei MH,Warren MB,Glenn GM,Turner ML,Stewart L,Duray P,Tourre O,Sharma N,Choyke P,Stratton P,Merino M,Walther MM,Linehan WM,Schmidt LS,Zbar B.Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell can-cer in families in North America.Am J Hum Genet 2003;73:95 -106[PMID:12772087 DOI:10.1086/376435]
76 Tomlinson IP,Alam NA,Rowan AJ,Barclay E,Jaeger EE,Kelsell D,Leigh I,Gorman P,Lamlum H,Rahman S,Roylance RR,Olpin S,Bevan S,Barker K,Hearle N,Houlston RS,Kiuru M,Lehtonen R,Karhu A,Vilkki S,Laiho P,Eklund C,Vierimaa O,Aittomki K,Hietala M,Sistonen P,Paetau A,Salovaara R,Herva R,Launonen V,Aaltonen LA.Germline mutations in FH predispose to dominantly inherited uterine fibroids,skin leiomyomata and papillary renal cell cancer.Nat Genet 2002;30:406-410[PMID:11865300 DOI:10.1038/ng849]
77 Wei MH,Toure O,Glenn GM,Pithukpakorn M,Neckers L,Stolle C,Choyke P,Grubb R,Middelton L,Turner ML,Walther MM,Merino MJ,Zbar B,Linehan WM,Toro JR.Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer.J Med Genet 2006;43:18-27[PMID:15937070 DOI:10.1136/jmg.2005.033506]
78 Reed WB,Walker R,Horowitz R.Cutaneous leiomyomata with uterine leiomyomata.Acta Derm Venereol 1973;53:409 -416[PMID:4127477]
79 Merino MJ,Torres-Cabala C,Pinto P,Linehan WM.The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma(HLRCC)syndrome.Am J Surg Pathol 2007;31:1578-1585[PMID:17895761 DOI:10 .1097/PAS.0b013e31804375b8]
80 Sanz-Ortega J,Vocke C,Stratton P,Linehan WM,Merino MJ.Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer(HLRCC)syndrome.Am J Surg Pathol 2013;37:74-80[PMID:23211287 DOI:10.1097/PAS.0b013e31825ec16f]
81 Michal M,Hes O,Nemcova J,Sima R,Kuroda N,Bulimbasic S,Franco M,Sakaida N,Danis D,Kazakov DV,Ohe C,Hora M.Renal angiomyoadenomatous tumor:morphologic,immunohistochemical,and molecular genetic study of a distinct entity.Virchows Arch 2009;454:89-99[PMID:19020896DOI:10.1007/s00428-008-0697-3]
82 Kuhn E,De Anda J,Manoni S,Netto G,Rosai J.Renal cell carcinoma associated with prominent angioleiomyoma-like proliferation:Report of 5 cases and review of the literature.Am J Surg Pathol 2006;30:1372-1381[PMID:17063076 DOI:10 .1097/01.pas.0000213277.45715.82]
83 Shannon BA,Cohen RJ,Segal A,Baker EG,Murch AR.Clear cell renal cell carcinoma with smooth muscle stroma.Hum Pathol 2009;40:425-429[PMID:18789480 DOI:10.1016/j.humpath.2008.05.021]
84 Michal M,Hes O,Kuroda N,Kazakov DV,Hora M.Difference between RAT and clear cell papillary renal cell carcinoma/clear renal cell carcinoma.Virchows Arch 2009;454:719 [PMID:19471960 DOI:10.1007/s00428-009-0788-9]
85 Kuroda N,Hosokawa T,Michal M,Hes O,Sima R,Ohe C,Lee GH.Clear cell renal cell carcinoma with focal renal angiomyoadenomatous tumor-like area.Ann Diagn Pathol 2011;15 :202-206[PMID:20952290 DOI:10.1016/j.anndiagpath.2010.03.003]
86 Kuroda N,Michal M,Hes O,Taguchi T,Tominaga A,Mizobuchi K,Ohe C,Sakaida N,Uemura Y,Shuin T,Lee GH.Renal angiomyoadenomatous tumor:fluorescence in situ hybridization.Pathol Int 2009;59:689-691[PMID:19712141DOI:10.1111/j.1440-1827.2009.02429.x]
87 Petersson F,Yan B,Huang J,Thamboo TP,Bing TK,Consigliere DT.Low-grade renal carcinoma with histologic features overlapping with renal angiomyoadenomatous tumor and featuring polysomy 7 and 17 and a mutation in the von Hippel-Lindau gene:report of a hybrid tumor and a few comments on renal angiomyoadenomatous tumor and papillary renal tumors with clear cells.Ann Diagn Pathol 2011;15:213 -216[PMID:21396864 DOI:10.1016/j.anndiagpath.2010.10.005]
88 Verine J.Renal angiomyoadenomatous tumor:morphologic,immunohistochemical,and molecular genetic study of a distinct entity.Virchows Arch 2009;454:479-480[PMID:19205727 DOI:10.1007/s00428-009-0741-y]